WINDLAS BIOTECH
Back to Income Statement
|
WINDLAS BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹66 Cr | ₹61 Cr | ₹58 Cr | ₹43 Cr | ₹38 Cr |
What is the latest Consolidated Net Profit of WINDLAS BIOTECH ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹66 Cr |
| Mar2025 | ₹61 Cr |
| Mar2024 | ₹58 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹38 Cr |
How is Consolidated Net Profit of WINDLAS BIOTECH Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹66 Cr | 8.95 | |
| Mar2025 | ₹61 Cr | 4.82 | |
| Mar2024 | ₹58 Cr | 36.51 | |
| Mar2023 | ₹43 Cr | 11.91 | |
| Mar2022 | ₹38 Cr | - | |
Compare Consolidated Net Profit of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,044.7 Cr | -8.4% | -14.1% | 8.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,483.0 Cr | -3.2% | -7.8% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,248.0 Cr | 1% | 0.9% | 67.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,822.0 Cr | -1.8% | -4.8% | 32.2% | Stock Analytics | |
| CIPLA | ₹105,427.0 Cr | -3.1% | -6.5% | -12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,492.3 Cr | -1.7% | 3.1% | -3.5% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -8.4% |
-14.1% |
8.4% |
| SENSEX | -1.2% |
-6.4% |
-10.8% |
You may also like the below Video Courses